INVITRO STUDY FOR THE OPTIMAL PRODUCTION OF HEPATITIS B VIRUS SUBVIRAL PARTICLES FOR MEDICAL PURPOSES
Last updated: 03 Jan 2025
10.21608/absb.2020.111456
Hepatitis B virus subviral particles, HepG2.2.15 cell line, polyethylene glycol, Virion-based vaccine candidate
Reda
Suef
A.
Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt,
redasuef@hotmail.com
Ezz Elden
Mohamed
M.
Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt,
Mohamed
Mansour
T.
Virology and Immunology Department, National Cancer Institute, Cairo University and Children's Cancer Hospital 57357
Mohamed
Farag
M.
Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt,
31
Issue 1-C
17024
2020-06-01
2020-01-21
2020-06-01
11
19
1110-2535
2636-3305
https://absb.journals.ekb.eg/article_111456.html
https://absb.journals.ekb.eg/service?article_code=111456
1
Original Article
520
Journal
Al-Azhar Bulletin of Science
https://absb.journals.ekb.eg/
INVITRO STUDY FOR THE OPTIMAL PRODUCTION OF HEPATITIS B VIRUS SUBVIRAL PARTICLES FOR MEDICAL PURPOSES
Details
Type
Article
Created At
22 Jan 2023